Terra Nova Asset Management LLC grew its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 15.5% during the fourth quarter, HoldingsChannel reports. The firm owned 5,574 shares of the medical research company’s stock after purchasing an additional 748 shares during the period. Thermo Fisher Scientific makes up approximately 1.8% of Terra Nova Asset Management LLC’s portfolio, making the stock its 27th biggest holding. Terra Nova Asset Management LLC’s holdings in Thermo Fisher Scientific were worth $1,058,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. Viking Global Investors LP acquired a new position in shares of Thermo Fisher Scientific in the fourth quarter worth approximately $154,660,000. Guggenheim Capital LLC lifted its stake in shares of Thermo Fisher Scientific by 5.9% in the fourth quarter. Guggenheim Capital LLC now owns 315,461 shares of the medical research company’s stock worth $59,899,000 after acquiring an additional 17,552 shares during the period. QS Investors LLC lifted its stake in shares of Thermo Fisher Scientific by 4.6% in the fourth quarter. QS Investors LLC now owns 19,804 shares of the medical research company’s stock worth $3,760,000 after acquiring an additional 865 shares during the period. Virtue Capital Management LLC acquired a new position in shares of Thermo Fisher Scientific in the fourth quarter worth approximately $127,000. Finally, Clearbridge Investments LLC lifted its stake in shares of Thermo Fisher Scientific by 5.3% in the fourth quarter. Clearbridge Investments LLC now owns 2,862,399 shares of the medical research company’s stock worth $543,512,000 after acquiring an additional 143,518 shares during the period. 86.79% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts recently commented on the company. ValuEngine raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Bank of America lifted their price objective on Thermo Fisher Scientific from $235.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, February 1st. Morgan Stanley lifted their price objective on Thermo Fisher Scientific from $223.00 to $227.00 and gave the stock an “overweight” rating in a research note on Thursday, February 1st. Barclays lifted their price objective on Thermo Fisher Scientific from $225.00 to $245.00 and gave the stock an “overweight” rating in a research note on Thursday, February 1st. Finally, Leerink Swann reaffirmed an “outperform” rating and issued a $239.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Thursday, February 1st. They noted that the move was a valuation call. Two analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $220.50.
Shares of Thermo Fisher Scientific Inc. (NYSE TMO) opened at $217.89 on Friday. The firm has a market capitalization of $87,544.71, a P/E ratio of 38.91, a price-to-earnings-growth ratio of 1.60 and a beta of 1.15. The company has a quick ratio of 0.92, a current ratio of 1.34 and a debt-to-equity ratio of 0.74. Thermo Fisher Scientific Inc. has a 1-year low of $151.74 and a 1-year high of $226.44.
Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.13. The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.72 billion. Thermo Fisher Scientific had a return on equity of 16.01% and a net margin of 10.64%. The firm’s revenue for the quarter was up 22.1% on a year-over-year basis. During the same period in the previous year, the company posted $2.41 earnings per share. equities analysts anticipate that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be issued a $0.17 dividend. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date of this dividend is Wednesday, March 14th. Thermo Fisher Scientific’s payout ratio is presently 10.71%.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.tickerreport.com/banking-finance/3255690/terra-nova-asset-management-llc-purchases-748-shares-of-thermo-fisher-scientific-inc-tmo.html.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.